» Articles » PMID: 26056760

Development of a Best Evidence Statement for the Use of Pressure Therapy for Management of Hypertrophic Scarring

Overview
Journal J Burn Care Res
Specialty Emergency Medicine
Date 2015 Jun 10
PMID 26056760
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Pressure therapy has been considered standard, first-line intervention for the treatment of hypertrophic scars since its introduction in the 1960s. Although widely used, this scar management technique has historically been based on a wide array of anecdotal evidence as opposed to strong scientific support. Evidence has become more prevalent in recent years, necessitating a synthesis to develop an evidence-based clinical guideline. The clinical question was asked, "Among individuals with or at risk to develop active hypertrophic scars, does treatment with pressure therapy improve aesthetic and functional outcomes?" An evidence-based practice project was completed with aims to synthesize relevant literature to determine recommendations for the use of pressure therapy in individuals at risk for hypertrophic scars. A systematic search of the literature was conducted for the dates January 1950 to February 2014 of the following databases: MEDLINE, CINAHL, Cochrane Database for Systematic Reviews, Burntherapist.com, Cochrane Libraries, Ebsco, Google Scholar, OT Seeker, Ovid, MedLine, PEDro.org, Pubmed.gov, Pubmed Clinical Queries, and hand search of relevant articles through use of reference lists. Search terms included scar, hypertroph*, pressure therapy, compression therapy, pressure garment, burn, scald, trauma as well as MeSH terms cicatrix and hypertrophic. Articles were reviewed in terms of ability to answer the clinical question as well as strength of conclusions. A total of 45 articles were found and critiqued, 28 of which were relevant to the clinical question. Evidence strength ranged from level 1 to level 5. Results from the studies were synthesized to create clinical recommendations to guide treatment. Based on best available evidence, it is recommended that pressure therapy is utilized to decrease scar height and erythema that it is used for grafts and wounds requiring 14 to 21 days to heal, for 23 hours/day for 12 months, fit to achieve 20 to 30 mm Hg of pressure, fit by a skilled technician, and replaced every 2-3 months. In addition, it is not recommended that pressure therapy is used to treat abnormal pigmentation, nor used to hasten scar maturation. This literature search revealed insufficient evidence addressing the impact of pressure therapy on scar pliability. Among individuals with or at risk to develop active hypertrophic scars, treatment with pressure therapy does improve outcomes, particularly for aesthetic concerns including scar thickness and erythema. Applicability of research to practice: The practical treatment recommendations presented may improve consistency and efficacy of pressure therapy utilization at the point of care.

Citing Articles

Scarring Skin: Mechanisms and Therapies.

Lin X, Lai Y Int J Mol Sci. 2024; 25(3).

PMID: 38338767 PMC: 10855152. DOI: 10.3390/ijms25031458.


Which Moisturizer to Use in Scar Therapy after Burn Injuries? A Subjective and Objective Skin and Scar Evaluation after Topical Treatment with Dexpanthenol, Aloe Vera, and Plant Oil.

Bagheri M, Werres M, Fuchs P, Seyhan H, Lefering R, Grieb G Medicina (Kaunas). 2023; 59(10).

PMID: 37893592 PMC: 10608183. DOI: 10.3390/medicina59101874.


Influence of Moisturizers on Skin Microcirculation: An Assessment Study Using Laser Speckle Contrast Imaging.

De Decker I, Klotz T, Vu P, Hoeksema H, De Mey K, Beeckman A J Pers Med. 2023; 13(10).

PMID: 37888118 PMC: 10608544. DOI: 10.3390/jpm13101507.


Efficacy and Safety of Pressure Therapy Alone and in Combination with Silicone in Prevention of Hypertrophic Scars: A Systematic Review with Meta-analysis of Randomized Controlled Trials.

Zhang P, Wu Q, Ding H, Bai R, Meng F, Xu X Aesthetic Plast Surg. 2023; 47(5):2159-2174.

PMID: 37648929 DOI: 10.1007/s00266-023-03591-w.


Extracellular vesicles from Lactobacillus druckerii inhibit hypertrophic scar fibrosis.

Han F, Wang K, Shen K, Wang J, Han S, Hu D J Nanobiotechnology. 2023; 21(1):113.

PMID: 36978136 PMC: 10053340. DOI: 10.1186/s12951-023-01861-y.